Lanxing Wang PhD , Zeming Yu MD , Yanwen Zhang PhD , Zhuangzhuang Yang PhD , Jie Zhao MD , Deling Kong PhD , Yuebing Wang PhD
{"title":"荧光和生物发光诱导多能干细胞的产生及其在类器官发育跟踪中的应用。","authors":"Lanxing Wang PhD , Zeming Yu MD , Yanwen Zhang PhD , Zhuangzhuang Yang PhD , Jie Zhao MD , Deling Kong PhD , Yuebing Wang PhD","doi":"10.1016/j.nano.2025.102849","DOIUrl":null,"url":null,"abstract":"<div><div>Islet organoids hold significant promise as a renewable source of insulin-producing cells for diabetes therapy; however, an efficient system for real-time tracking and dynamic capture of the developmental processes of islet organoids remains underdeveloped. Here, we report the generation of induced pluripotent stem cells (iPSCs) stably expressing enhanced green fluorescent protein (EGFP) and luciferase (Luc) via rational plasmid construction and lentiviral transduction. Using fluorescence and bioluminescence imaging, we systematically monitored the differentiation of these EGFP/Luc-iPSCs into islet organoids, demonstrating that the reporter iPSCs maintained pluripotency, stable fluorescent/bioluminescent signals, and uncompromised differentiation potential across multiple passages. The formed islet organoids consistently exhibited robust imaging signals, enabling noninvasive visualization of their spatiotemporal developmental dynamics. Our study established an innovative imaging platform that facilitates real-time, noninvasive monitoring of islet organoid morphogenesis, provides mechanistic insights into organoid differentiation pathways, and paves the way for advancing cell-based therapeutic strategies for diabetes.</div></div>","PeriodicalId":19050,"journal":{"name":"Nanomedicine : nanotechnology, biology, and medicine","volume":"69 ","pages":"Article 102849"},"PeriodicalIF":4.6000,"publicationDate":"2025-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Generation of fluorescent and bioluminescent induced pluripotent stem cells with their application in tracking organoid development\",\"authors\":\"Lanxing Wang PhD , Zeming Yu MD , Yanwen Zhang PhD , Zhuangzhuang Yang PhD , Jie Zhao MD , Deling Kong PhD , Yuebing Wang PhD\",\"doi\":\"10.1016/j.nano.2025.102849\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Islet organoids hold significant promise as a renewable source of insulin-producing cells for diabetes therapy; however, an efficient system for real-time tracking and dynamic capture of the developmental processes of islet organoids remains underdeveloped. Here, we report the generation of induced pluripotent stem cells (iPSCs) stably expressing enhanced green fluorescent protein (EGFP) and luciferase (Luc) via rational plasmid construction and lentiviral transduction. Using fluorescence and bioluminescence imaging, we systematically monitored the differentiation of these EGFP/Luc-iPSCs into islet organoids, demonstrating that the reporter iPSCs maintained pluripotency, stable fluorescent/bioluminescent signals, and uncompromised differentiation potential across multiple passages. The formed islet organoids consistently exhibited robust imaging signals, enabling noninvasive visualization of their spatiotemporal developmental dynamics. Our study established an innovative imaging platform that facilitates real-time, noninvasive monitoring of islet organoid morphogenesis, provides mechanistic insights into organoid differentiation pathways, and paves the way for advancing cell-based therapeutic strategies for diabetes.</div></div>\",\"PeriodicalId\":19050,\"journal\":{\"name\":\"Nanomedicine : nanotechnology, biology, and medicine\",\"volume\":\"69 \",\"pages\":\"Article 102849\"},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2025-08-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nanomedicine : nanotechnology, biology, and medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1549963425000504\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanomedicine : nanotechnology, biology, and medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1549963425000504","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
Generation of fluorescent and bioluminescent induced pluripotent stem cells with their application in tracking organoid development
Islet organoids hold significant promise as a renewable source of insulin-producing cells for diabetes therapy; however, an efficient system for real-time tracking and dynamic capture of the developmental processes of islet organoids remains underdeveloped. Here, we report the generation of induced pluripotent stem cells (iPSCs) stably expressing enhanced green fluorescent protein (EGFP) and luciferase (Luc) via rational plasmid construction and lentiviral transduction. Using fluorescence and bioluminescence imaging, we systematically monitored the differentiation of these EGFP/Luc-iPSCs into islet organoids, demonstrating that the reporter iPSCs maintained pluripotency, stable fluorescent/bioluminescent signals, and uncompromised differentiation potential across multiple passages. The formed islet organoids consistently exhibited robust imaging signals, enabling noninvasive visualization of their spatiotemporal developmental dynamics. Our study established an innovative imaging platform that facilitates real-time, noninvasive monitoring of islet organoid morphogenesis, provides mechanistic insights into organoid differentiation pathways, and paves the way for advancing cell-based therapeutic strategies for diabetes.
期刊介绍:
The mission of Nanomedicine: Nanotechnology, Biology, and Medicine (Nanomedicine: NBM) is to promote the emerging interdisciplinary field of nanomedicine.
Nanomedicine: NBM is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life and health sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases.